Jump to section
BrightCure's mission is to drive scientific innovation into women’s intimate health
UTIs affect millions of women in the UK alone and they can develop into life threatening infections. Current treatment relies on constant antibiotics and insufficient preventatives. BrightCure solves that problem by offering a range of bioactive products that promote vaginal health.
The company's products represent an attractive alternative to antibiotics, especially for those who suffer from regular UTIs. Compared to most traditional treatments, BrightCure's products focus on promoting better bacterial health.
BrightCure is headed up by a team of experienced scientists from Imperial College London, and this lends their products a high degree of credibility. They are also backed by Mithril, Firstmin, Calm/Storm & SOSV.
Freddie
Company Specialist at Welcome to the Jungle
Chiara Heide
(CEO)PhD Imperial College London. Excited to bring scientific innovation into the female health space. UTI patient herself & frustrated with the lack of solutions and antibiotics founded BrightCure herself.